top of page
shutterstock_647537386-1024x683.webp

THE WORLD'S MOST RESEARCHED PROBIOTIC (Bifidobacterium)

BB-12®️ probiotic is a patented strain of probiotic bacteria that has been extensively studied for its health benefits. It is a strain of Bifidobacterium animalis subsp. lactis, a type of bacteria that is naturally found in the human gut.

BB-12®️ has been clinically proven to show several potential health benefits, including improving digestive health, enhancing immune function, reducing gut inflammation, and even reducing allergenic symptoms. Studies have also shown that BB-12®️ can help prevent and treat conditions such as diarrhea, irritable bowel syndrome (IBS), and respiratory infections.

With over 400 scientific publications and over 200 human clinical trials, BB-12®️ probiotic is surely helpful in enhancing the digestive health and immune system of your child. 

probiotic.jpg

SUPERIOR QUALITY 
FDA & EFSA APPROVED

One of the reasons that BB-12®️ is so effective is that it is able to survive the harsh conditions of the digestive tract and reach the colon, where it can exert its beneficial effects. This is important, as many other probiotic strains are unable to survive this journey.

In addition to that, BB-12®️ probiotic is also the only probiotic that has been granted the status of Qualified Presumption of Safety (QPS) since 2007 by the European Food Safety Authority (EFSA) [1]. It has also received a Generally Recognized As Safe (GRAS) status by the Food and Drug Administration (FDA) in the US for both young toddlers and the general population [2].

All in all, BB-12®️ probiotic offers superior benefits and quality not only to adults, but young children as well. 

Source:

[1] EFSA Panel on Biological Hazards (BIOHAZ). Statement on the update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 3: Suitability of taxonomic units notified to EFSA until September 2015. EFSA Journal. 2015;13:4331.

[2] Food and Drug Administration. GRAS Notice Inventory > Agency Response Letter GRAS Notice No GRN 000049. 2002.

bottom of page